Prev Next

BP-C1 Oncology


BP-C1 is a unique product that clinically has proven to have both strong palliation properties as well as tumor control properties. .....read more

BP-C2 Radiation Defence


BP-C2 incorporates immunomodulating and chelating ligand and a molybdenum, needed for detoxification. .....read more

BP-C1 Oncology


BP-C1 is a unique product that clinically has proven to have both strong palliation properties as well as tumor control properties. .....read more

BP-C2

Radiomitigation

 

BP-C2 is a novel product based on Meabco’s patented technology platform. BP-C2 has favorable immunomodulating properties.
 

BP-C2 has been shown to have a strong effect on the hematopoietic system and GI system, helping these to recover after damages induced by disease, radiation and chemical agents.
 

BP-C2 increases the number of endogenous CFU-S by 1.6-2.0 times compared to those in the control group. BP-C2 demonstrates protection of the spleen, and improves time to recovery of bone marrow formation of blood cellular components and the quality of red bone marrow cells and blood values.
 

BP-C2 extends the animal’s lifetime up to 2 times (10 Gy) and 1.5 times (15 Gy) and animals exposed to 2-20 Gy revealed:

  • BP-C2 has a dose modifying factor of 1.26
  • LD50/30 of 6.56 Gy,
  • LD84/30 of 8.41 Gy.

Animals with low base line levels of metal ions, phosphate, blood proteins and blood cells experienced a pronounced increase without any sign of liver toxicity as the liver parameters, amylase, glucose, and creatinine remained normal.

When taken orally, BP-C2 protects the gastric crypt from damages, repairs gastrointestinal damages, and restores the gastric crypts. 
 

When applied topically, animals exposed to a radiation dose of 30 Gy (5x6Gy), developed swelling and ulcerations of grade 4 (wounds with pus) while animals receiving BP-C2 were protected from these injuries. 


MEABCO A/S  |  Richard Mortensens Vej 61  |  DK-2300 Copenhagen  |  Telephone: +45 32 46 03 70  | e-mail: info@meabco.com
Websitet anvender cookies til at huske dine indstillinger, statistik og at målrette annoncer. Når du besøger vores hjemmeside, accepterer du automatisk vores brug af Cookies.